Placebo: Clinical Trials

3 trials for Placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Placebo: new trials by email Literature Review of Placebo trials Research Report on Placebo

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
Suvorexant, Placebo - Suvorexant, Placebo
Phase 2CompletedJohns Hopkins University762022-03-302026-08-10
Neural Correlates of Hypoalgesia Driven by Observation
Naloxone, Saline - Pain, Virtual Reality
Phase 2CompletedUniversity of Maryland, Baltimore2112021-11-012026-04-16
The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
d-cycloserine, Sugar Pill - Treatment, Placebo
Phase 2CompletedHartford Hospital512008-01-012021-02-18

Narrower conditions

Opioid-Related Disorders (1)  ·  Pain (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Chemically-Induced Disorders (1)  ·  Dyssomnias (1)  ·  Mental Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

Cycloserine (1)  ·  Naloxone (1)  ·  Sodium Chloride (1)  ·  Sugars (1)  ·  suvorexant (1)

Sponsors

Hartford Hospital (1)  ·  Johns Hopkins University (1)  ·  University of Maryland, Baltimore (1)

Countries

United States (3)

Top investigators

Andrew S Huhn, Ph.D. (1)  ·  Gretchen J. Diefenbach, Ph.D. (1)  ·  Luana Colloca, MD/PhD/MS (1)

NIH funding

UH3DA048734 (1)